S Nasca

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

Y. Bécouarn, Marc Ychou, Michel Ducreux et al. · Journal of Clinical Oncology · 1998 · 301 citations

Pharmacy, Oncology, Pharmacotherapy +12

Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study

Thierry Conroy, B Paillot, Éric François et al. · Journal of Clinical Oncology · 2005 · 239 citations

Medicine, Oncology, Pharmacology +17

Comparative Effects of Antrocolic Transposition and Antrectomy on Fundic Mucosa and Acid Secretion of the Rat

Thérèse Lehy, Amélie Bonnefond, M Dubrasquet et al. · Gastroenterology · 1973 · 51 citations · Full text

Medicine, Physiology, Surgery +11

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials

Thomas Aparicio, Michel Ducreux, Roger Faroux et al. · European Journal of Cancer · 2018 · 46 citations · Full text

Medicine, Nutrition, Oncology +9

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients

J. F. Seitz, Jaafar Bennouna, B Paillot et al. · Annals of Oncology · 2002 · 39 citations

Medicine, Clinical Pharmacokinetics, Oncology +10